1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
Compound with spectra: 1 NMR
![1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE](/api/compound/843jSHQ5AMV.png?ph=true&h=300&w=458 "1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE")
| SpectraBase Compound ID | 843jSHQ5AMV |
|---|---|
| InChI | InChI=1S/C17H17ClN2O3S/c1-2-11-19-17(21)15-5-3-4-6-16(15)20(24(19,22)23)12-13-7-9-14(18)10-8-13/h3-10H,2,11-12H2,1H3 |
| InChIKey | LQEMTWDKVVLXEB-UHFFFAOYSA-N |
| Mol Weight | 364.85 g/mol |
| Molecular Formula | C17H17ClN2O3S |
| Exact Mass | 364.064841 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-BENZYL-3-ISOPROPYL-1H-2,1,3-BENZOTHIADIAZIN-(4)-3H-ONE 2,2-DIOXIDE
1-(PHENYLBUTHYL)-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
N-benzyl-4-[(1-(4-tert-butylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]cyclohexanecarboxamide
N-(4-methylbenzyl)-4-(1-(3-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)butanamide
N-(2-methoxybenzyl)-4-[(1-(4-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
N-(2-chlorobenzyl)-4-[(1-(4-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
N-(2-chlorobenzyl)-4-(1-(4-chlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)butanamide
1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOBUTYLOXY)-2,1,3-BENZOTHIADIAZIN-2,2-DIOXIDE
N-(2-chlorobenzyl)-5-(1-(4-chlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)pentanamide
N-(2-furylmethyl)-5-(1-(4-nitrobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)pentanamide
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |